Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Stocktreeon Jan 05, 2024 10:48am
198 Views
Post# 35812358

Back to their old empty pumping habits

Back to their old empty pumping habits
Now that the spectacular climb back up to EDT's periodic high point, none of the members of the PUMPCYCLE club is talking about the very near term possibiliy of a breakthrough anymore. They're just pitching wild calculations while intentionally forgetting key information.

MMs theory is that Baxter is likely to grab EDT before the market knows what is happening (helped in part by little old me and my bashing), which means retail shareholders would be left with nothing compared to any future where EDT is still standing on its own with its proprietary assets.

Well, if you take that into account, you cannot base any future SP on future sales, because we will already be out of the picture well before potential substantial sales are made.

And if you take the current price to sales ratio, you then get 73...
Not very attractive at all.

And it's alright, you can ignore me, my information is not for you anyway.
<< Previous
Bullboard Posts
Next >>